Case Law Details
In Re. M/s Laurus Labs Limited (GST AAR Andhra Pradesh)
Products manufactured by the applicant, even though are bulk drug gets squarely covered under List 1 of SI. No. 180 of the Schedule -I to the Notification No. 01/2017 Central Tax (Rate) dated 28.06.2017. Further as it is settled law that, the specific entry overrides the general entry, the commodities dealt by the applicant are covered by specific entries, the rate of tax applicable, is the rate specified against specific entry only.
Accordingly we pass the following ruling:
The applicant is eligible to claim the benefit of lower rate of GST i.e. 5% under SI. No. 180 of Schedule-I of the rate schedule under Notification No. 01/2017 Central Tax (Rate) dated 28.06.2017 read with the corrigendum dated 30.06. 2017 on supply of 1. EFAVIRENZ 2. EMTRICITABINE 3. SUNTINIB MALATE 4 RALTEGRAVR POTASIUM 5. LATANOPROST.
FULL TEXT OF ADVANCE RULING
Please become a Premium member. If you are already a Premium member, login here to access the full content.
